Skip to main content

Find Clinical Trials

Home
Conditions
Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 Mutation

Clinical trial condition

Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 Mutation

Explore clinical trials studying Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 Mutation. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 Mutation trial results

Not Yet Recruiting

Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma

NCT07712757

Conditions: Astrocytoma, Astrocytoma IDH Mutant Grade 2, Glioma, +11 more
Locations: Not specified

View Trial Details